ARP-4922

N/A

Report date: 2024/06/07 14:41:22
NME

Base Information

Drug NameARP-4922
Drug Alias NameARP-4922
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor erythroid 2-related factor 2 degraders
TargetsNuclear factor erythroid 2-related factor 2
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArpeggio Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesArpeggio Biosciences Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A